Immune modulatory effects of progesterone on oxLDL-induced trained immunity in monocytes.
cardiovascular disease
oxLDL
progesterone
steroid hormone
trained immunity
Journal
Journal of leukocyte biology
ISSN: 1938-3673
Titre abrégé: J Leukoc Biol
Pays: England
ID NLM: 8405628
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
pubmed:
19
1
2022
medline:
27
7
2022
entrez:
18
1
2022
Statut:
ppublish
Résumé
Atherosclerotic cardiovascular diseases (CVD) are among the leading causes of death in the world. Monocyte-derived macrophages are key players in the pathophysiology of atherosclerosis. Innate immune memory following exposure of monocytes to atherogenic compounds, such as oxidized low-density lipoproteins (oxLDL), termed trained immunity, can contribute to atherogenesis. The current study aimed to elucidate intracellular mechanisms of oxLDL-induced trained immunity. Using untargeted intracellular metabolomics in isolated human primary monocytes, we show that oxLDL-induced trained immunity results in alterations in the balance of intracellular steroid hormones in monocytes. This was reflected by a decrease in extracellular progesterone concentrations following LPS stimulation. To understand the potential effects of steroid hormones on trained immunity, monocytes were costimulated with oxLDL and the steroid hormones progesterone, hydrocortisone, dexamethasone, β-estradiol, and dihydrotestosterone. Progesterone showed a unique ability to attenuate the enhanced TNFα and IL-6 production following oxLDL-induced trained immunity. Single nucleotide polymorphisms in the nuclear glucocorticoid, progesterone, and mineralocorticoid receptor were shown to correlate with ex vivo oxLDL-induced trained immunity in 243 healthy volunteers. Pharmacologic inhibition experiments revealed that progesterone exerts the suppression of TNFα in trained immunity via the nuclear glucocorticoid and mineralocorticoid receptors. Our data show that progesterone has a unique ability to suppress oxLDL-induced trained immunity. We hypothesize that this effect might contribute to the lower incidence of CVD in premenopausal women.
Identifiants
pubmed: 35040511
doi: 10.1002/JLB.3AB1220-846R
pmc: PMC9544104
doi:
Substances chimiques
Glucocorticoids
0
Lipoproteins, LDL
0
Tumor Necrosis Factor-alpha
0
oxidized low density lipoprotein
0
Progesterone
4G7DS2Q64Y
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
279-288Informations de copyright
© 2022 The Authors. Journal of Leukocyte Biology published by Wiley Periodicals LLC on behalf of Society for Leukocyte Biology.
Références
Hum Mol Genet. 2016 Dec 1;25(23):5167-5177
pubmed: 27798095
Atherosclerosis. 2011 Feb;214(2):345-9
pubmed: 21167486
N Engl J Med. 2019 Dec 26;381(26):2497-2505
pubmed: 31733140
Cell. 2018 Jan 11;172(1-2):135-146.e9
pubmed: 29328908
Am J Cardiol. 2002 Jun 20;89(12A):12E-17E; discussion 17E-18E
pubmed: 12084397
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W71-7
pubmed: 20457745
J Clin Invest. 2020 Oct 1;130(10):5591-5602
pubmed: 32692728
Cell. 2018 Jan 11;172(1-2):162-175.e14
pubmed: 29328911
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Anal Chem. 2011 Sep 15;83(18):7074-80
pubmed: 21830798
Cardiovasc Drugs Ther. 2015 Aug;29(4):319-27
pubmed: 26006701
Clin Vaccine Immunol. 2016 Dec 5;23(12):926-933
pubmed: 27733422
Immunology. 2008 Sep;125(1):59-69
pubmed: 18373668
J Mol Med (Berl). 2020 Jun;98(6):819-831
pubmed: 32350546
J Immunol. 2000 Jul 15;165(2):618-22
pubmed: 10878331
Front Immunol. 2019 Aug 07;10:1859
pubmed: 31440248
Horm Mol Biol Clin Investig. 2014 May;18(2):89-103
pubmed: 25390005
Cell Rep. 2016 Dec 6;17(10):2562-2571
pubmed: 27926861
J Leukoc Biol. 2022 Aug;112(2):279-288
pubmed: 35040511
Sci Rep. 2019 Feb 26;9(1):2772
pubmed: 30809020
Immunol Lett. 2009 Aug 15;125(2):151-5
pubmed: 19607861
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1731-8
pubmed: 24903093
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
Cell Metab. 2019 Jul 2;30(1):1-2
pubmed: 31204280
Circ Res. 2020 Jul 3;127(2):269-283
pubmed: 32241223
N Engl J Med. 2020 Nov 5;383(19):1838-1847
pubmed: 32865380
Cardiovasc Res. 2020 Feb 1;116(2):317-328
pubmed: 31119285
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Life Sci. 1996;59(1):1-14
pubmed: 8684265
J Cell Mol Med. 2017 May;21(5):1024-1032
pubmed: 27957792
Immunometabolism. 2021 Jun 30;3(3):e210025
pubmed: 34267957
PLoS One. 2012;7(11):e50167
pubmed: 23209664
Atherosclerosis. 2016 Nov;254:228-236
pubmed: 27764724
J Leukoc Biol. 2018 Sep;104(3):573-578
pubmed: 30153369
Semin Immunopathol. 2018 Feb;40(2):203-214
pubmed: 28971272
Cell Rep. 2020 Apr 21;31(3):107548
pubmed: 32320649
J Immunol Methods. 2003 Jul;278(1-2):283-92
pubmed: 12957415